Douglas E. Lorenz

890 total citations
30 papers, 658 citations indexed

About

Douglas E. Lorenz is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Douglas E. Lorenz has authored 30 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Infectious Diseases and 10 papers in Hepatology. Recurrent topics in Douglas E. Lorenz's work include Hepatitis Viruses Studies and Epidemiology (10 papers), Viral gastroenteritis research and epidemiology (9 papers) and Animal Virus Infections Studies (8 papers). Douglas E. Lorenz is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (10 papers), Viral gastroenteritis research and epidemiology (9 papers) and Animal Virus Infections Studies (8 papers). Douglas E. Lorenz collaborates with scholars based in United States, Canada and Switzerland. Douglas E. Lorenz's co-authors include Steven A. Goldman, Robert S. Mansbach, Paul Albrecht, John C. Petricciani, Hope E. Hopps, J Drucker, Roslyn E. Wallace, J. Wagner, Ruth L. Kirschstein and R. J. Gerety and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Douglas E. Lorenz

28 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas E. Lorenz United States 14 272 210 191 94 86 30 658
Philip P. McGrath United States 9 288 1.1× 100 0.5× 140 0.7× 126 1.3× 6 0.1× 13 660
R. Siegert Germany 18 371 1.4× 435 2.1× 15 0.1× 47 0.5× 27 0.3× 66 1.0k
Joel B. Erickson United States 7 233 0.9× 201 1.0× 25 0.1× 28 0.3× 10 0.1× 7 544
Н. Т. Райхлин Russia 10 155 0.6× 110 0.5× 12 0.1× 25 0.3× 113 1.3× 26 595
Nigel Horscroft United States 16 334 1.2× 239 1.1× 122 0.6× 47 0.5× 8 0.1× 23 1.0k
Michael Lyon Australia 9 143 0.5× 152 0.7× 17 0.1× 43 0.5× 23 0.3× 11 417
Andrea S. Bertke United States 18 463 1.7× 171 0.8× 42 0.2× 42 0.4× 21 0.2× 34 883
Carlos F. Arias Mexico 15 131 0.5× 484 2.3× 22 0.1× 60 0.6× 53 0.6× 20 866
Warren K. Ashe United States 13 197 0.7× 67 0.3× 10 0.1× 54 0.6× 19 0.2× 18 555
R. Scheid Germany 8 189 0.7× 125 0.6× 239 1.3× 11 0.1× 7 0.1× 15 380

Countries citing papers authored by Douglas E. Lorenz

Since Specialization
Citations

This map shows the geographic impact of Douglas E. Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Lorenz more than expected).

Fields of papers citing papers by Douglas E. Lorenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Lorenz. The network helps show where Douglas E. Lorenz may publish in the future.

Co-authorship network of co-authors of Douglas E. Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. Lorenz. A scholar is included among the top collaborators of Douglas E. Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. Lorenz. Douglas E. Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grest, Paula, et al.. (1996). [Field study with a vaccine against enzootic pneumonia of swine].. PubMed. 138(10). 483–9. 6 indexed citations
2.
Lorenz, Douglas E., et al.. (1985). Incidences of antibodies to hepatitis B, herpes simplex and cytomegalovirus in prostitutes. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 259(2). 275–283. 8 indexed citations
3.
Mansbach, Robert S. & Douglas E. Lorenz. (1983). Cholecystokinin (CCK-8) elicits prandial sleep in rats. Physiology & Behavior. 30(2). 179–183. 52 indexed citations
4.
Lorenz, Douglas E., et al.. (1982). Infection of marmosets with parainfluenza virus types 1 and 3. Infection and Immunity. 37(3). 1037–1041. 6 indexed citations
5.
Albrecht, Paul, et al.. (1980). Fatal measles infection in marmosets pathogenesis and prophylaxis. Infection and Immunity. 27(3). 969–978. 54 indexed citations
6.
Drucker, J, L. A. Smallwood, Douglas E. Lorenz, et al.. (1979). Serologic response in human hepatitis A: Detection of antibody by radioimmunoassay and immune adherence hemagglutination. Journal of Medical Virology. 4(1). 51–58. 9 indexed citations
7.
Huang, S N, Douglas E. Lorenz, & Robert J. Gerety. (1979). Electron and immunoelectron microscopic study on liver tissues of marmosets infected with hepatitis A virus.. PubMed. 41(1). 63–71. 22 indexed citations
8.
Shimizu, Yohko K., et al.. (1978). Localization of Hepatitis A Antigen in Liver Tissue by Peroxidase-Conjugated Antibody Method: Light and Electron Microscopic Studies. The Journal of Immunology. 121(5). 1671–1679. 31 indexed citations
9.
Heegaard, Peter M. H., et al.. (1978). Localization of Hepatitis A Antigen in Marmoset Organs during Acute Infection with Hepatitis A Virus. The Journal of Infectious Diseases. 138(3). 369–377. 67 indexed citations
10.
Dienstag, Jules L., et al.. (1976). Virus-like particles and GB agent hepatitis. Nature. 264(5583). 260–261. 11 indexed citations
11.
Dienstag, Jules L., Robert J. Gerety, Jay H. Hoofnagle, et al.. (1976). Hepatitis a Antigen Isolated from Liver and Stool: Immunologic Comparison of Antisera Prepared in Guinea Pigs. The Journal of Immunology. 117(3). 876–881. 10 indexed citations
12.
Lorenz, Douglas E., et al.. (1975). Review of infectivity studies in nonhuman primates with virus-like particles associated with MS-1 hepatitis. The American Journal of the Medical Sciences. 270(1). 81–85. 29 indexed citations
13.
Hoofnagle, J H, et al.. (1975). Hepatitis A Antigen in Liver, Bile and Stool. Proceedings annual meeting Electron Microscopy Society of America. 33. 340–341. 1 indexed citations
14.
Wallace, Roslyn E., et al.. (1973). Development of a diploid cell line from fetal rhesus monkey lung for virus vaccine production. In Vitro Cellular & Developmental Biology - Plant. 8(5). 323–332. 30 indexed citations
15.
Wallace, Roslyn E., et al.. (1973). Development and characerization of cell lines from subhuman primates. In Vitro Cellular & Developmental Biology - Plant. 8(5). 333–341. 49 indexed citations
16.
Hayflick, Leonard, John C. Petricciani, Hope E. Hopps, & Douglas E. Lorenz. (1972). Human virus vaccines: why monkey cells?. PubMed. 176(4036). 813–4. 9 indexed citations
17.
Petricciani, John C., Hope E. Hopps, & Douglas E. Lorenz. (1971). Subhuman Primate Diploid Cells: Possible Substrates for Production of Virus Vaccines. Science. 174(4013). 1025–1027. 19 indexed citations
18.
Rabson, Alan S., Gregory T. O’Conor, Douglas E. Lorenz, et al.. (1971). Lymphoid Cell-Culture Line Derived From Lymph Node of Marmoset Infected With <italic>Herpesvirus saimiri</italic>—Preliminary Report. JNCI Journal of the National Cancer Institute. 46(5). 1099–109. 36 indexed citations
19.
Lorenz, Douglas E., et al.. (1970). Hepatitis in the Marmoset, Saguinus mystax. Experimental Biology and Medicine. 135(2). 348–354. 25 indexed citations
20.
Luborsky, Samuel W., et al.. (1967). On the production of highly labeled tumor virus deoxyribonucleic acid.. Proceedings of the National Academy of Sciences. 57(5). 1286–1293.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip P. McGrath Breakdown of academic impact, for papers by R. Siegert Breakdown of academic impact, for papers by Joel B. Erickson Breakdown of academic impact, for papers by Н. Т. Райхлин Breakdown of academic impact, for papers by Nigel Horscroft Breakdown of academic impact, for papers by Michael Lyon Breakdown of academic impact, for papers by Andrea S. Bertke Breakdown of academic impact, for papers by Carlos F. Arias Breakdown of academic impact, for papers by Warren K. Ashe Breakdown of academic impact, for papers by R. Scheid
Rankless by CCL
2026